Finding expert sarcoma care can be overwhelming – and that’s OK. SARC is here for you. We help support patients, families, and their caregivers on their journey through sarcoma.

Not sure where to start? Call the Sarcoma Helpline for guidance and consultation.

Yellow Ribbon

Find a clinical trial

Patient with doctor during treatment

Choosing a treatment path and whether or not to participate in a clinical trial can be a very difficult decision. This is a question only you, those close to you, and health professionals familiar with your situation can consider and answer together.

Find a sarcoma center

The Sarcoma Centers Directory is a listing and map of sarcoma institutions, centers, and practices worldwide. Each center has a summary page with self-reported, detailed information, including useful contacts.

Research Advocacy Council

Patient holding doctor hand

The SARC Research Advocacy Council seeks motivated patient advocates who are passionate about helping to support and drive sarcoma research advancements.

why choose a clinical trial?

Patient holding doctor hand

It is often thought that clinical trials are a last resort, but they may in fact be a good way to begin your treatment and receive excellent care from the very start.

SARC EDUCATIONAL VIDEO

Adoptive Cell Therapy is a type of cancer treatment that uses your own immune system to treat your cancer; it may be an option for patients with some types of sarcoma. To learn more, speak with your doctor. 

SARC is grateful to Dr. Seth Pollack, Northwestern University, for his expert guidance in producing this SARC-developed educational video.

Peter Fantozzi

patient advocate & representative

“I got involved [in patient advocacy] because I’ve been passionate about cancer research ever since I was diagnosed with cancer when I was 11-years old. So now as a 12-year survivor the SARC Research Advocacy Council really allows me to do a few things. 1. It allows me to give back to a cause that is important; 2. It allows me to develop my skills as a psycho-oncology researcher; and 3. It allows me to fill a need for patient advocates.”

Back to top